From model cell line to in vivo gene expression: Disease-related intestinal gene expression in IBD

Genes and Immunity

Volumn 9, Issue 3, 2008, Pages 240-248

  Schulze, H A ^a,b   Hasler R ^a   Mah, N ^a   Lu, T ^a   Nikolaus, S ^a   Costello, C M ^a,c   Schreiber, S ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC PROTEIN; HEAT SHOCK PROTEIN 40; HISTAMINE METHYLTRANSFERASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; PROPLATELET BASIC PROTEIN; PROTEIN DNAJ; TRANSCRIPTION FACTOR JUNB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; ENTERITIS; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-THROMBOGLOBULIN; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 4; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; HSP40 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1ALPHA; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-JUN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 42549168130     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.11     Document Type: Article

References (81)

1. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus environment in inflammatory bowel disease: Results of a British twin study. BMJ 1996; 312: 95-96.
2. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124: 1767-1773.
3. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-823.
4. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004; 36: 476-480.
5. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471-475.
6. Potocnik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 2004; 5: 530-539.
7. Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R te al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 2003; 73: 1282-1292.
8. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 2000; 66: 1857-1862.
9. Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 1998; 115: 1066-1071.
10. Hampe J, Frenzel H, Mirza MM, Croucher PJ, Cuthbert A, Mascheretti S et al. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci USA 2002; 99: 321-326.
11. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000; 35: 154-167.
12. Schwerbrock N, Makkink M, van der Sluis M, Buller H, Einerhand A, Sartor R et al. Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria. Inflamm Bowel Dis 2004; 10: 811-823.
13. MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 1996; 31: 907-916.
14. Autschbach F, Braunstein J, Helmke B, Zuna I, Schurmann G, Niemir ZI et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 1998; 153; 121-130.
15. van Deventer SJ. Review article: Targeting TNF alpha as a key cytokine in the inflaymmatory processes of Crohn's disease - the mechanisms of action of infliximab. Aliment Pharmacol Ther 1999; 13: 3-8.
16. Kollias G, Douni E, Kassiotis G, Kontoyiannis D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 1999; 169: 175-194.
17. Cohen RD. Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience. Inflamm. Bowel Dis 2001; 7 (Suppl 1): S17-S22.
18. Farrell RJ, Shah SA, Lodhavia PJ, Alsahli M, Falchuk KR, Michetti P et al. Clinical experience with infliximab therapy in 100 patients with Crohns disease. Am J Gastroenterol 2000; 95: 3490-3497.
19. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF et al. Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet 2002; 359: 1541-1549.
20. Vermeire S, Louis E, Carbonez A, Van Assche G, Noman M, Belaiche J et al. Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease. Am J Gastroenterol 2002; 97: 2357-2363.
21. Ljung T, Karlen P, Schmidt D, Hellstrom PM, Lapidus A, Janczewska I et al. Infliximab in inflammatory bowel disease: Clinical outcome in a population based cohort from Stockholm County. Gut 2004; 53 849-853.
22. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Plum Genet 2000; 66: 1863-1870.
23. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223-228.
24. Piguet PP, Vesin C, Donati Y, Barazzone C. TNF-induced enterocyte apoptosis and detachment in mice: Induction of caspases and prevention by a caspase inhibitor, ZVAD-fmk. Lab Invest 1999; 79: 495-500.
25. Mizoguchi E, Mizoguchi A, Takedatsu H, Cario E, de Jong YP, Ooi CJ et al. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology 2002; 122: 134-144.
26. Fukushima K, Yonezawa H, Fiocchi C. Inflammatory bowel disease-associated gene expression in intestinal epithelial cells by differential cDNA screening and mRNA display. Inflamm Bowel Dis 2003; 9: 290-301.
27. Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003; 52: 840-846.
28. Garat C, Arend WP. Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways. Cytokine 2003; 23: 31-40.
29. Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW et al Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: Screening by DNA microarrays. Inflamm Bowel Dis 2004; 10: 1-14.
30. He X, Sugawara M, Takekuma Y, Miyazaki K. Absorption of ester prodrugs in CaCo-2 and rat intestine models. Antimicrob Agents Chemother 2004; 48: 2604-2609.
31. Watanabe Y, Jacob CO. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell. J Immunol 1991; 146: 899-905.
32. Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 2002; 168 5342-5351.
33. Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello C et al. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol 2004; 138: 323-329.
34. Andus T, Daig R, Vogl D, Aschenbrenner E, Lock G, Hollerbach S et al Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Gut 1997; 41: 651-657.
35. Arai Y, Takanashi H, Kitagawa H, Okayasu I. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 1998; 10: 890-896.
36. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998; 42: 470-476.
37. Camoglio L, Te Velde AA, Tigges AJ, Das PK, Van Deventer SJ. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 1998; 4: 285-290.
38. Jarry A, Vallette G, Cassagnau E, Moreau A, Bou-Hanna C, Lemarre P et al. Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer. Gut 1999; 45: 246-251.
39. Lahav M, Levite M, Bassani L, Lang A, Fidder H, Tal R et al. Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells. Clin Exp Immunol 2002; 127: 226-233.
40. Madrigal-Estebas L, Doherty DG, O'Donoghue DP, Feighery C, O'Farrelly C. Differential expression and upregulation of interleukin-1alpha, interleukin-1beta and interleukin-6 by freshly isolated human small intestinal epithelial cells. Mediators Inflamm 2002; 11: 313-319.
41. Matikainen S, Tapiovaara H, Vaheri A, Hurme M. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells. Cell Growth Differ 1994; 5: 975-982.
42. Shanker G, Sorci-Thomas M, Register TC, Adams MR. The inducible expression of THP-1 cell interleukin-1 mRNA: Effects of estrogen on differential response to phorbol ester and lipopolysaccharide. Lymphokine Cytokine Res 1994; 13: 1-7.
43. MacNaul KL, Hutchinson NI, Parsons JN, Bayne EK, Tocci MJ. Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J Immunol 1990; 145: 4154-4166.
44. de Caestecker MP, Telfer BA, Hutchinson IV, Ballardie FW. The detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha expression in human monocytes using two colour immunofluorescence flow cytometry. J Immunol Methods 1992; 154 11-20.
45. Bailly S, Ferrua B, Fay M, Gougerot-Pocidalo MA. Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: Role of cyclic AMP. Cytokine 1990; 2: 205-210.
46. Gaffney EV, Stoner CR, Lingenfelter SE, Wagner LA. Demonstration of IL-1 alpha, and IL-1 beta secretion by the monocytic leukemia cell line, THP-1. J Immunol Methods 1989; 122: 211-218.
47. McAlindon ME, Hawkey CJ, Mahida YR. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 1998; 42: 214-219.
48. Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998; 43: 33-39.
49. Reimund JM, Wittersheim C, Dumont S, Muller CD, Baumann R, Poindron P et al. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996; 16: 144-150.
50. ÓDonovan N, Galvin M, Morgan J. Physical mapping of the CXC chemokine locus on human chromosome 4. Cytogenet Cell Genet 1999; 84: 39-42.
51. Ina K, Kusugami K, Yamaguchi T, Imada A, Hosokawa T, Ohsuga M et al Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease. Am J Gastroenterol 1997; 92: 1342-1346.
52. McCormack G, Moriarty D, ÓDonoghue D, McCormick P, Sheahan K, Baird A. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001; 50: 491-495.
53. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA et al. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994; 144: 997-1007.
54. Nielsen O, Rüdiger N, Gaustadnes M, Horn T. Intestinal interleukin-8 concentration and gene expression in inflammtory bowel disease. Scand J Gastroenterol 1997; 32: 1028-1034.
55. Schenk BI, Petersen F, Flad HD, Brandt E. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-act vating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration. J Immunol 2002; 169: 2602-2610.
56. Schaffner A, King CC, Schaer D, Guiney DG. Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. J Leukoc Biol 2004; 76: 1010-1018.
57. Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: Potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 2004; 263 115-124; discussion 124-32, 211-8.
58. Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermuller N et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281: G216-G228.
59. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004; 286: G367-G376.
60. Flanagan LA, Chou J, Falet H, Neujahr R, Hartwig JH, Stossel TP. Filamin A, the Arp2/3 complex, and the morphology and function of cortical actin filaments in human melanoma cells. J Cell Biol 2001; 155: 511-517.
61. Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, Stossel TP et al. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol 2002; 4: 681-690.
62. Castellazzi M, Spyrou G, La Vista N, Dangy JP, Piu F, Yaniv M et al Overexpression of c-jun, junB, or junD affects cell growth differently. Proc Natl Acad Sci USA 1991; 88: 8890-8894.
63. Jess T, Loftus Jr EV, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC et al. Risk of intestinal cancer in inflammatory bowel disease: A population-based study from olmsted county, Minnesota. Gastroenterology 2006; 130: 1039-1046.
64. Hayashi A, Seki N, Hattori A, Kozuma S, Saito T. PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu. Biochim Biophys Acta 1999; 1450: 99-106.
65. Knutson L, Ahrenstedt O, Odlind B, Hallgren R. The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology 1990; 98: 849-854.
66. Raithel M, Matek M, Baenkler H, Jorde W, Hahn E. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol 1995, 108 127-133.
67. Garcia-Martin E, Mendoza J, Martinez C, Taxonera C, Urcelay E, Ladero J et al. Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J Gastroenterol 2006; 12: 615-620.
68. Chen M, Roti J, Laszlo A. Hsc40, a new member of the hsp40 family, exhibits similar expression profile to that of hsc70 in mammalian cells. Gene 1999; 238: 333-341.
69. Ohtsuka K, Hata M. Mammalian HSP40/DNAJ homologs: Cloning of novel cDNAs and a proposal for their classification and nomenclature. Cell Stress Chaperones 2000; 5: 98-112.
70. Sato S, Oka M, Noguchi Y, Soda H, Tsurutani J, Nakamura Y et al. Autoimmunity to heat shock protein 40 in ulcerative colitis. J Int Med Res 2004; 32: 141-148.
71. Ohkawara T, Nishihira J, Ishiguro Y, Otsubo E, Nagai K, Takeda H et al. Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice. Immunol Lett 2006; 107: 148-154.
72. Okamura R, Sigvardsson M, Galceran J, Verbeek S, Clevers H, Grosschedl R. Redundant regulation of T cell differentiation and TCR alpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity 1998; 8: 11-20.
73. van de Wetering M, Oosterwegel M, Holstege F, Dooyes D, Suijkerbuijk R, Geurts van Kessel A et al. The human T cell transcription factor-1 gene. Structure, localization, and promoter characterization. J Biol Chem 1992; 267: 8530-8536.
74. Eickhoff H, Schuchhardt J, Ivanov I, Meier-Ewert S, O'Brien J, Malik A et al. Tissue gene expression analysis using arrayed normalized cDNA libraries. Genome Res 2000; 10: 1230-1240.
75. Boer JM, Huber WK, Sultmann H, Wilmer F, von Heydebreck A, Haas S et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31 500-element cDNA array. Genome Res 2001; 11: 1861-1870.
76. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
77. Mah N, Thelin A, Lu T, Nikolaus S, Kuhbacher T, Gurbuz Y et al. A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics 2004; 16: 361-370.
78. Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, Hahn A et al Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2005; 2: E199.
79. Hoyle DC, Rattray M, Jupp R, Brass A. Making sense of microarray data distributions. Bioinformatics 2002; 18: 576-584.
80. Lu T, Costello CM, Croucher PJ, Hasler R, Deuschl G, Schreiber S. Can Zipf's law be adapted to normalize microarrays? BMC Bioinformatics 2005; 6: 37.
81. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.